Article
Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections.
Journal of viral hepatitis - 1 May 1996
Bayraktar Y, Koseoglu T, Temizer A, Kayhan B, Van Thiel D H, Uzunalimoglu B
Abstract excerpt
Unravelling the role of interferon (IFN) in the treatment of chronic hepatitis B compliance by many factors. Several mutant forms of hepatitis B virus (HBV) have recently been discovered; the most common of these is the precore mutant, characterized by hepatitis B e antigen (HBeAg) negativity and...
Topics
- Adult
- Alanine Transaminase
- Antiviral Agents
- Chronic Disease
- Drug Resistance, Microbial
- Female
- Ferritins
- Genetic Variation
- Hepatitis B
- Hepatitis B Antibodies
- Hepatitis B Core Antigens
- Hepatitis B e Antigens
- Hepatitis B virus
- Humans
- Interferon-alpha